Results
225
Companies which are more than 50% undervalued based on analyst price target.
225 companies
Telix Pharmaceuticals
Market Cap: AU$6.2b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$18.40
7D
8.7%
1Y
-2.1%
Resolute Mining
Market Cap: AU$1.4b
Engages in mining, prospecting, and exploration of mineral properties in Africa.
RSG
AU$0.67
7D
-3.6%
1Y
-2.2%
Clarity Pharmaceuticals
Market Cap: AU$1.3b
A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.
CU6
AU$3.44
7D
-0.3%
1Y
-50.1%
Alpha HPA
Market Cap: AU$1.1b
Operates as a specialty metals and technology company.
A4N
AU$0.97
7D
3.7%
1Y
16.2%
Silex Systems
Market Cap: AU$1.1b
A technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom.
SLX
AU$4.03
7D
14.5%
1Y
-10.0%
Regal Partners
Market Cap: AU$960.2m
A privately owned hedge fund sponsor.
RPL
AU$2.74
7D
-9.0%
1Y
-19.2%
Vulcan Energy Resources
Market Cap: AU$933.0m
Engages in the geothermal energy, and lithium exploration and production activities in Europe, Germany, and Australia.
VUL
AU$3.98
7D
12.1%
1Y
5.6%
PYC Therapeutics
Market Cap: AU$755.3m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.30
7D
1.6%
1Y
-4.1%
Kingsgate Consolidated
Market Cap: AU$751.7m
Engages in the exploration, development, and mining of gold and silver mineral properties.
KCN
AU$2.93
7D
3.9%
1Y
119.5%
Opthea
Market Cap: AU$738.8m
A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.
OPT
AU$0.60
7D
0%
1Y
23.7%
Clinuvel Pharmaceuticals
Market Cap: AU$677.6m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$13.55
7D
16.1%
1Y
-2.5%
EBR Systems
Market Cap: AU$616.2m
Develops implantable systems for wireless tissue stimulation.
EBR
AU$1.37
7D
9.6%
1Y
23.4%
Weebit Nano
Market Cap: AU$585.8m
Develops a non-volatile memory using a Resistive RAM (ReRAM) technology based on fab-friendly materials in Israel and France.
WBT
AU$2.81
7D
3.3%
1Y
33.2%
Tamboran Resources
Market Cap: AU$550.9m
A natural gas company, focuses on developing unconventional gas resources in the northern territory of Australia.
TBN
AU$0.15
7D
-3.1%
1Y
3.3%
Turaco Gold
Market Cap: AU$535.9m
Engages in the mineral exploration of gold deposits in Cote d’Ivoire.
TCG
AU$0.51
7D
4.1%
1Y
96.2%
Brazilian Rare Earths
Market Cap: AU$533.9m
Focuses on the exploration of rare earth elements and other critical minerals in Brazil.
BRE
AU$2.15
7D
7.5%
1Y
-19.2%
Santana Minerals
Market Cap: AU$499.8m
Engages in the exploration and evaluation of gold and silver properties in New Zealand, Cambodia, and Mexico.
SMI
AU$0.60
7D
3.4%
1Y
7.4%
Sovereign Metals
Market Cap: AU$475.5m
Engages in the exploration and development of mineral resource projects in Malawi.
SVM
AU$0.73
7D
-0.7%
1Y
19.5%
Metro Mining
Market Cap: AU$469.6m
Operates as an exploration and mining company in China.
MMI
AU$0.077
7D
6.9%
1Y
108.1%
Lotus Resources
Market Cap: AU$462.5m
Engages in the exploration, evaluation, and development of uranium properties in Africa.
LOT
AU$0.20
7D
30.0%
1Y
-17.0%
Omni Bridgeway
Market Cap: AU$448.5m
Offers dispute and litigation finance services in Australia, the United States, Canada, Latin America, Asia, New Zealand, Europe, the Middle East, and Africa.
OBL
AU$1.56
7D
3.3%
1Y
85.1%
WIA Gold
Market Cap: AU$446.6m
Engages in the exploration and evaluation of mineral properties in Namibia and Côte d’Ivoire.
WIA
AU$0.33
7D
0%
1Y
209.5%
Imricor Medical Systems
Market Cap: AU$435.8m
A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.
IMR
AU$1.36
7D
0%
1Y
177.6%
BrainChip Holdings
Market Cap: AU$427.5m
Develops software and hardware accelerated solutions for artificial intelligence and machine learning applications in North America, Oceania, Europe, the Middle East, and Asia.
BRN
AU$0.21
7D
10.5%
1Y
23.5%
Bell Financial Group
Market Cap: AU$412.2m
Engages in the provision of full-service broking, online broking, corporate finance, and financial advisory services to private, institutional, and corporate clients in Australia, the United States, the United Kingdom, Hong Kong, and Kuala Lumpur.
BFG
AU$1.29
7D
3.6%
1Y
-8.2%
Antipa Minerals
Market Cap: AU$407.9m
Engages in the mineral exploration business in Australia.
AZY
AU$0.63
7D
17.8%
1Y
384.6%
Audinate Group
Market Cap: AU$396.7m
Engages in develops and sells digital audio visual (AV) networking solutions Australia and internationally.
AD8
AU$4.71
7D
-7.6%
1Y
-52.0%
Strike Energy
Market Cap: AU$395.7m
An independent gas producer, explores for and develops oil and gas resources in Australia.
STX
AU$0.12
7D
14.3%
1Y
-36.8%
Alliance Aviation Services
Market Cap: AU$383.2m
Provides contract, charter, and allied aviation services in Australia and internationally.
AQZ
AU$2.38
7D
-7.8%
1Y
-20.7%
Beetaloo Energy Australia
Market Cap: AU$377.5m
Together its subsidiaries, engages in the production and sale of oil and natural gas in Australia.
BTL
AU$0.30
7D
13.0%
1Y
19.6%
Ausgold
Market Cap: AU$370.8m
Explores for gold and other precious metals in Australia.
AUC
AU$0.88
7D
44.6%
1Y
124.4%
NOVONIX
Market Cap: AU$362.2m
A battery technology and materials company, provides products and mission critical services in North America, Asia, Australia, and Europe.
NVX
AU$0.56
7D
23.3%
1Y
-7.5%
Immutep
Market Cap: AU$359.6m
A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.24
7D
0%
1Y
-35.5%
Titomic
Market Cap: AU$350.9m
Offers manufacturing and technology solutions for high-performance metal additive manufacturing in Australia, the United States, and Europe.
TTT
AU$0.23
7D
2.2%
1Y
39.4%
Magnetic Resources
Market Cap: AU$340.8m
Engages in the exploration of mineral tenements in Western Australia.
MAU
AU$1.27
7D
-5.9%
1Y
-19.9%
Meteoric Resources
Market Cap: AU$330.1m
Explores for mineral tenements in Brazil, Canada, Western Australia, and Northern Territory.
MEI
AU$0.13
7D
-7.4%
1Y
25.0%